You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 10,495,653


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,495,653
Title:Stabilization of labile analytes in reference materials
Abstract: Provided herein are assay control materials comprising stable analytes and lyophilized unstable analytes, and methods of making and using the same.
Inventor(s): Ebrahim; Alireza (Laguna Niguel, CA), De Vore; Karl (Coto de Caza, CA), Spates; Christopher (Laguna Hills, CA)
Assignee: Bio-Rad Laboratories, Inc. (Hercules, CA)
Application Number:15/411,775
Patent Claims:1. A method of preparing a control from an analyte control kit, the method comprising, suspending in a solution at least one unstable control analyte that is lyophilized in the form of beads or microspheres that contain a pre-determined amount of the at least one unstable control analyte to form a suspended unstable analyte, wherein the solution is a base matrix solution from a biological sample from which the unstable control analyte has been removed, wherein the base matrix comprises an antibiotic agent, wherein the base matrix comprises polyethylene glycol or human hemoglobin, and wherein the base matrix is a biological sample selected from processed urine, lymph, urine from which bilirubin or creatinine or both bilirubin and creatinine have been removed from the urine, milk, mucus, cell lysate, or tissue culture, wherein the processed urine is generated by a method comprising contacting urine with creatininase to remove creatinine from the urine.

2. The method of claim 1, wherein the base matrix comprises at least one stable control analyte.

3. The method of claim 2, wherein the at least one stable control analyte is selected from the group consisting of amylase, calcium, chloride, cortisol, glucose, hCG, magnesium, microalbumin, phosphorus, potassium, sodium, urea nitrogen, and uric acid.

4. The method of claim 3, wherein the base matrix further comprises one or more of ketones, leukocyte esterase, nitrite, protein, and urobilinogen.

5. The method of claim 1, wherein the at least one unstable control analyte is suspended in the solution to form two separate suspended unstable analyte solutions, wherein the two separate unstable analyte solutions have different concentrations of the unstable analyte.

6. The method of claim 1, further comprising: combining a stable control analyte with the suspended unstable analyte.

7. The method of claim 1, wherein the at least one unstable control analyte is selected from the group consisting of creatinine, bilirubin, salicylate, triglyceride, alanine aminotransferase (ALT), alkaline phosphatase, high density lipoprotein, pseudocholinesterase, folate, and homocysteine.

8. A method of preparing a control from an analyte control kit, the method comprising, suspending in a solution at least one unstable control analyte that is lyophilized in the form of beads or microspheres that contain a pre-determined amount of the at least one unstable control analyte to form a suspended unstable analyte, wherein the at least one unstable control analyte is bilirubin or creatinine or both bilirubin and creatinine, wherein the solution is a base matrix solution from a biological sample from which the unstable control analyte has been removed, wherein the base matrix comprises an antibiotic agent, and wherein the base matrix is urine.

9. The method of claim 8, wherein the base matrix comprises at least one stable control analyte.

10. The method of claim 8, wherein the at least one unstable control analyte is suspended in the solution to form two separate suspended unstable analyte solutions, wherein the two separate unstable analyte solutions have different concentrations of the unstable analyte.

11. The method of claim 8, wherein the base matrix comprises polyethylene glycol, human serum albumin, bovine serum albumin, or human hemoglobin.

12. A method of preparing a control from an analyte control kit, the method comprising, suspending in a solution at least one unstable control analyte that is lyophilized in the form of beads or microspheres that contain a pre-determined amount of the at least one unstable control analyte to form a suspended unstable analyte, wherein the solution is a base matrix solution from a biological sample from which the unstable control analyte has been removed, wherein the base matrix comprises an antibiotic agent, and wherein the base matrix is processed urine that was generated in a method comprising contacting urine with creatininase to remove creatinine from the urine.

13. The method of claim 12, wherein the base matrix comprises at least one stable control analyte.

14. The method of claim 12, wherein the at least one unstable control analyte is suspended in the solution to form two separate suspended unstable analyte solutions, wherein the two separate unstable analyte solutions have different concentrations of the unstable analyte.

15. The method of claim 12, wherein the base matrix comprises polyethylene glycol, human serum albumin, bovine serum albumin, or human hemoglobin.

16. The method of claim 12, wherein the at least one unstable control analyte is selected from the group consisting of creatinine, bilirubin, salicylate, triglyceride, alanine aminotransferase (ALT), alkaline phosphatase, high density lipoprotein, pseudocholinesterase, folate, and homocysteine.

17. The method of claim 12, wherein the at least one unstable control analyte is bilirubin or creatinine or both bilirubin and creatinine.

Details for Patent 10,495,653

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 10/21/1942 ⤷  Try a Trial 2033-05-06
Baxalta Us Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 03/03/1954 ⤷  Try a Trial 2033-05-06
Csl Behring Ag ALBURX albumin (human) Injection 102366 07/23/1976 ⤷  Try a Trial 2033-05-06
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.